Plaintiffs Move to Create Bextra, Celebrex MDL

WASHINGTON - Plaintiffs who recently filed Bextra and Celebrex complaints in federal courts around the country have moved to consolidate the petitions before a single judge in Louisiana. In Re Bextra and Celebrex Litigation, MDL Docket No. n/a (JPML)

Filed immediately after Pfizer announced April 7 that it was withdrawing Bextra from the market and that Celebrex would carry new warnings related to cardiovascular risks, the motion requests that the Judicial Panel on Multidistrict Litigation create an MDL for all Bextra and Celebrex-related claims filed against Pfizer. The motion seeks transfer and consolidation of the federal lawsuits to a federal …